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Study objectives: To study circulatory endotoxin (ET) in patients with sepsis syndrome (SS) in order to answer three questions: (a) How often and at which concentration is ET present in the plasma of patients with SS and is the presence of ET a prognostic marker in this situation? (b) Is detection of ET helpful in predicting Gramnegative bacterial infections with or without bacteremia? (c) What are the kinetics of clearance of ET concentrations in plasma? Design: Prospective study of consecutive patients fulfilling Bone's criteria for SS. Setting: Medical ICU in a teaching hospital. Patients: The study included 93 patients. The simplified acute physiologic score was 19 ± 6, 49 percent were in shock, and 54 percent were mechanically ventilated. The mortality at day 28 was 53 percent. Measurements: Endotoxin determinations and blood cultures were performed simultaneously at the onset (day 1) of SS. Samples were collected on several days from 48 patients. Endotoxin concentration was determined using an end point chromogenic Limulus assay. For the first ET determination, the mean circulatory level (mean ± SEM) was calculated among patients with detectable ET, thus excluding patients with a null value for ET. Results: On day 1, ET was detected in 44 patients (47 percent; 60.2 ± 16.5 pg/ml) and was statistically more frequent in patients with shock, elevated plasma lactate, and organ failure. There was no statistical difference for age, gender, ratio of PaO2 to fraction of inspired oxygen.
Sepsis associated with organ dysfunction or shock, or both, is still a leading cause of death and is on the rise.1'2 Gram-negative bacteria (GNB) account for approximately 50 percent of documented infections. '3'4 There are several lines of evidence for the participation of endotoxin (ET) originating from GNB in the inflammatory response observed in patients with severe GNB-related sepsis.5'6 Treatments aimed at neutralizing or antagonizing ET have been tried for more than 20 years. Although initial *From the Intensive Care Unit (Drs. Guidet, Vassal, and Offenstadt), and Bacteriology Department (Drs. Barakett and Petit), Saint-Antoine Hospital, Paris.
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Patient Eligibility
Over an 18-month period (September 1992 through March 1993), 93 patients admitted to the ICU of Saint Antoine Hospital fulfilled the criteria for SS as defined by Bone et all and were consecutively included in the study. Among these patients, 48 had serial daily samplings over a 10-month period. Shock was defined as a systolic blood pressure below 90 mm Hg for more than 1 h, which was unresponsive to plasma expanders and requiring inotropic or vasoactive agents (dopamine or norepinephrine), or both. Disseminated intravascular coagulation was defined as either a drop in the platelet count of 25 percent or more plus a greater than 20 percent increase in prothrombin or a greater than 20 percent partial thromboplastin time plus D-dimer more than 0.5 ng-L.-l The initial blood samples were obtained as soon as possible after admission and the delay between the beginning of SS (defined by the first organ dysfunction) and the first sampling was noted. The severity was assessed by the simplified acute physiologic score (SAPS)'7 and organ system failure (OSF).18
Survival was defined as being alive at 28 days after meeting criteria for SS. Immunosuppression was defined as the presence of one of the following: AIDS, solid tumor treated with chemotherapy, any hematologic cancer, or steroid treatment (>0.5 mg/kg of body weight per day). Among the 93 patients who consented to participate, 17 were included in a prospective double-blind, placebo-controlled randomized, multicenter trial of a monoclonal antibody to tumor necrosis factor-alpha. Two patients with purpura fulminans had received HA-lA.
Collection of Data and Blood Sampling
Samples for determination of circulating total ET and for blood cultures were collected simultaneously from each patient. The first sampling was performed after a mean of 16 ± 3 h after the first organ dysfunction.
Endotoxin Assay: Blood (4 ml) was collected through a peripheral vein into nominally sterile ET-free plastic tubes containing sodium heparin, 120 IU (Endotube -Chromogenix). No ET was detected in empty tubes filled with pyrogen-free water. After sampling, the tubes were immediately immersed in ice.
Centrifugation was performed within 1 h after sampling (190 g for 10 min at 4°C) and platelet-rich plasma (PRP) was separated and stored at -200C (Falcon tubes) until the assay was performed. The determination of the ET concentration was based on an end point Limulus assay as described by Van Deventer et al. 15 All samples were processed in a laminar flow hood. Inhibiting and enhancing plasma components were eliminated by dilution (tenfold in pyrogen-free water) and heating (15 min at 75°C) before the assay was performed. Diluted heated PRP (50 ml) was incubated in a microtiter plate with the Limulus amebocyte lysate (LAL) (50 ml) for 40 min at 370C, and chromogenic substrate S 2423 was added followed by 5 min of continued incubation. The optical density values at 405 nm were read after addition of 50 percent acetic acid (50 ml). All assays were performed in duplicate and blanks were obtained by addition of acetic acid prior to addition of the substrate. The ET concentrations were read on a standard curve in PRP. Standard curves were drawn with ET prepared from Escherichia coli 0111: B4 diluted in ET-negative PRP from healthy donors. The lower detection limit is 5 pg/ml (0.06 ET unit/ml) and the assay time is 2.5 h. A standard dose of 20 pg/ml of ET (spike) was added to each sample. This procedure enabled us to test the effectiveness of the heating-dilution step. The recovery of spiked ET in PRP from patients is calculated as follows: ( The within-and between-assay variation coefficients of the assay at 100 pg/ml PRP were 6 and 5 percent, respectively. At 10 pg/ml PRP, values of 10 and 15 percent were obtained.
Blood Cultures: Ten milliliters of blood was distributed into aerobic and anaerobic bottles (BCB Combi set, Roche). According to the results of blood cultures obtained at the time of the first ET determination, GNB infections were classified into three groups: (1) 
Statistical Analysis
For continuous variables, means + SEM were calculated, and absolute and relative frequencies were measured for discrete variables. Differences between groups were examined for statistical significance by a Mann Whitney U Test in the case of continuous variables and by Fisher's exact test in the case of discrete variables.
For the first ET determination, the mean circulatory level was calculated among patients with detectable ET, thus excluding patients with a null value for ET. For the sequential analysis of ET, the means were calculated including all patients with detectable ET at least once. Most of these patients with initial positive circulatory ET tested negative on a secondary test, so these null ET values were integrated into the calculations of means of ET at days 2, 3, and 4.
RESULTS

General Characteristics of the Patients With Sepsis Syndrome
Patients: The severity of the condition of the 93 patients studied was assessed by a SAPS of 19 ± 6 ( Table 1 ). The condition of the patients at the time of the first sampling was as follows: shock, 49 percent; mechanical ventilation, 54 percent; anuria requiring hemodialysis, 6 percent. The population was mainly (27) 8 (18) 17 (35) Kidney 16 (17) 13 (30) 3 (6) Peritoneum 13 (14) 8 (18) 33 .3 percent, and to noninfectious etiology (even after autopsy) in 17.2 percent of the patients. The primary sites of infection were the lung (27 percent), the kidney (17 percent), the peritoneum (14 percent), the meninx (5 percent), and miscellaneous areas (37 
Results of Initial Endotoxin Determination
Endotoxin was detectable in the plasma of 44 patients (47 percent). Among these patients, the mean value of circulatory ET was 60.2 ± 16.5 pg/ml (range, 6 to 574 pg/ml). It is interesting to note that patients without a documented source of infection had detectable ET at a frequency similar to the rest of the population with quantitative values even higher, although the difference was not statistically significant ( Table 2 ). The patients with GNB infections were more frequently endotoxemic than pa- tients without GNB infection, but once ET was present, the quantitative values were similar in the two groups (Table 2 ). According to the primary site of infection, ET was detected in 40, 50, 54, and 80 percent, respectively, for lung, kidney, peritoneum, and cerebrospinal infections.
Endotoxin was detected significantly more often in patients with shock, multiple organ dysfunctions, or elevated plasma lactate levels. Age, gender, SAPS, or outcome were not significantly different among patients with or without detectable plasma ET ( Table  3) .
The results for patients with proven GNB infection are indicated in Table 4 . The endotoxemic patients were younger and had a tendency to be more severely ill than the nonendotoxemic patients. Twenty-six patients had shock with ET detectable in 77 percent (66 ± 6 pg/ml), and the frequency of detectable endotoxemia was similar whether they had bacteremia (n = 17; ET, 74 percent) or not (n = 9; ET, 67 percent). The patients with GNB bacteremia were studied in terms of the delay between the blood culture and the first ET determination. Among the 19 patients with positive GNB blood cultures simultaneous to the first ET determination, ET was detected in 15 (79 percent, 61 ± 22 pg/ml). The four patients without endotoxemia had E coli (n = 2), Haemophilus influenzae (n = 1), and Bacteroides fragilis (n = 1) bacteremia. Fourteen other patients had positive blood cultures less than 48 h before the first sampling for ET, while the blood cultures performed simultaneous to the ET determination were negative (they had received antibiotics in the meanwhile). In this subgroup, ET was detected in 9 patients (64 percent; 36 ± 6.5 pg/ml), while 5 patients with E coli bacteremia had no detectable ET. The prevalence of detectable ET or its concentration was not statistically different between the patients with previous or simultaneous positive GNB blood cultures. Thirteen patients had a documented GNB infection without any positive blood culture. In this group, ET was detected in 7 patients (54 percent; 87.6 ± 52.6).
Among the six patients without endotoxemia, three had peritonitis and three, pyelonephritis. At Sepsis and septic shock remain a leading cause of death, and there are several lines of experimental evidence to suggest that ET is implicated. The natural history of ET in human septic disease is not well documented, although extensive antilipopolysaccharide (LPS) treatment trials have been performed. In this study, we investigate whether a rapid endotoxin assay would be useful in identifying a population with a high risk of death and who could benefit from anti-LPS or anticytokine therapy. We found that quantitative or qualitative values for ET did not discriminate between patients with or without documented infection. Moreover, we were unable to find any differences among patients with GNB infection whether they had bacteremia or not and this further questions the subgroup analysis performed in the recently published anti-LPS treatment trails.9"11 The lack of differences in the level of ET among survivors and nonsurvivors also has been found by Casey et al2l and the relationship between plasma ET levels and severity of the condition has been questioned. 22 However, Danner et al14 found a higher mortality among endotoxemic patients, and in the case of systemic meningococcal disease, there was also a correlation between endotoxemia and the mortality rate23 as well as between ET level as assessed by LAL assay and by gas chromatography.24 These differences could be partly explained by a variation in the degree of ET toxicity depending on the strains. For example, Danner et al14 showed that Psuedomonas aeruginosa-infected dogs were sicker than dogs infected with E coli despite an ET concentration tenfold lower. 25 We found that simple clinical and biological criteria such as the presence of shock, acidosis, hypoxemia, hypothermia, and the site of infection were good predictors of mortality. Calandra et a126
found similar results in a multicriteria analysis, and in this study tumor necrosis factor was not a good factor for predicting mortality. Casey et al2' were required to express LPS and cytokines values as a score in order to find a correlation between this score and mortality. Even with this score, the prediction was weak for the patients with sepsis of intermediate severity.
In summary, we believe that initial circulatory ET assessed by the LAL chromogenic method should not be used as a criteria for inclusion in anticytokine trials or even in anti-LPS trials.
Prediction of Gram-Negative Bacteremia With Endotoxin
It is difficult to predict GNB infection from simple clinical factors. 27 The accuracy of prediction by physicians of GNB bacteremia is no more than 40 percent either in the United States9 or in France.28 So ET determinations could be useful for that purpose. This has been tried since 197029 with overall poor results. In 1979, Elin30 analyzed the results of 17 reported studies and concluded that the clinical relevance of the LAL assay for predicting GNB bacteremia could not be established. The breakthrough came with the development of an increased sensitivity of the LAL assay by using chromogenic substrates and with the improvement of methods for eliminating plasma activators and inhibitors.31 However, even with these new assays, the recently published results of ET are mixed (Table 5 ). These discrepancies could be explained by several factors: the assays for ET are not standardized (gelification or chromogenic methods, different techniques for elimination of plasma activators and inhibitors, different LPS and vehicles used for standard curves). The se- In our patients, the sensitivity and specificity of ET for GNB bacteremia at the time of admission were 79 percent and 61 percent, respectively (Table 5) . When all patients with GNB bacteremia were pooled (n = 33), the sensitivity was 73 percent and specificity, 67 percent.
What are the hypotheses to explain the lack of ET plasma detection while GNB are present in the blood (false-negative results)?
1. Presence of plasma inhibitors of the LAL. This has been ruled out, since exogenously added ET (spiked sample) was recovered, indicating that the dilution-heating procedure was accurate.
2. Endotoxin with no activity on the LAL. This biologically inactive ET already has been described. 35 This outlines that the LAL assay tests the capacity of plasma to activate the LAL cascade, but that it is not a true and direct measurement of ET. What are the hypotheses to explain ET plasma detection in spite of the absence of documented GNB infection (false-positive results)?
1. Endotoxin translocating from the digestive tract. Intestinal endotoxemia without bacteremia has been described in several experimental animal models.36 Acute bowel ischemia is a common phenomenon in patients with septic shock and could explain the low level of ET in patients without GNB infection. Interestingly, among the 47 patients without GNB infection, ET The mechanism of ET cleatance is still not completely understood but involves natural anti-ET antibodies, binding to high-density liproproteins and macrophages. Endotoxin administered by bolus infusion in animals is cleared in less than 3 h, while in slow infusion it is more slowly.38 In a recent report, a laboratory worker self administered intravenously 1 mg of Salmonella minnesota ET, a dose that is about 4,000 times higher than the dose used for studying ET effects in healthy volunteers. He developed shock and multisystem organ failure. The circulatory cytokines (tumor necrosis factor alpha, IL-1, IL-6, and IL-8) were very high 3.6 and 6.8 h after the injection, but ET in serum was only slightly elevated 6.8 h after injection and below the detection limit after 11.5 thology seems questionable. Among the 17 GNB bacteremic patients of our study with serial ET determinations, we were unable to find any relationship between evolution of ET level and outcome. However, the design of our study does not allow us to draw firm conclusions about the effect of antibiotics on ET release.
CONCLUSION
In our study, plasma ET concentrations predict neither Gram-negative infection with or without bacteremia, nor the outcome. However, when ET is present in the plasma of patients with SS, it remains detectable for a long period of time as compared with its rapid plasma disappearance in animals or healthy human volunteers receiving ET intravenously. This slow clearance of ET suggests either a continuous release or a defect in its clearance.
